SPR Therapeutics
-
Recon
New SPR Therapeutics Data Presented at ASRA Pain Medicine Meeting 2023
Three Posters Accepted Including a President’s Choice Award for New Data from a Randomized Controlled Trial on Total Knee Replacement…
Read More » -
Spine
SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference
CLEVELAND, March 16, 2023 (GLOBE NEWSWIRE) — SPR Therapeutics, a private medical device company focused on treating pain and improving…
Read More » -
Neuro
SPR Therapeutics Names Dr. Peter Staats as Chief Medical Advisor
CLEVELAND, Jan. 15, 2019 (GLOBE NEWSWIRE) — SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced…
Read More » -
Extremities
SPR Therapeutics Awarded $1.6M NIH Grant to Study Pain Management Following Knee Replacement Surgery Using the Sprint™ PNS System
CLEVELAND, OH–(Marketwired – Aug 25, 2015) – SPR® Therapeutics has been awarded a $1.6M grant from the National Institute on…
Read More »